Barun Bhhatarai PhD

Dr. Bhhatarai is an Investigator for Pharmacokinetic Sciences (PCS) department at Novartis Institute for Biomedical Research (NIBR) at Cambridge, MA. He has over 10 years of experience in using various ML and data analytics techniques to support small molecule drug discovery projects. At Novartis, he guides project team members from several therapeutic areas, to mitigate ADMET and PK/PD related issues during the lead optimization and drug candidate selection stages.

Prior to that, Dr. Bhhatarai was Systems Toxicology Informatics Fellow in the Predictive Safety Assessment Center at The Dow Chemical Company in Midland, MI. Here, he was responsible for the development, assessment, and implementation of novel in-silico alternative approaches aimed at predicting potential mammalian and environmental health effects. He was involved in various Systems Toxicology research projects. He also contributed actively in various workshops related to acute toxicity advocating Alternative Approaches for Identifying Acute Systemic Toxicity. Dr. Bhhatarai is a member of the American Society for Cellular and Computational Toxicology (ASCCT), the American Chemical Society (ACS), the IQ Consortium, and the Society of Toxicology (SOT). He has authored 25+ peer-reviewed publications and several presentations.